Drug Search Results
More Filters [+]

SM-04554

Alternative Names: sm-04554, sm04554, sm 04554
Latest Update: 2021-08-11
Latest Update Note: News Article

Product Description

SM04554 is a novel small molecule, topical scalp treatment for AGA targeting the Wnt pathway, a pathway known to regulate hair growth.

Mechanisms of Action: Wnt Activator

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Biosplice Therapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for SM-04554

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Alopecia Areata

Phase 1: Alopecia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SM04554-AGA-05

P3

Completed

Alopecia Areata

2020-12-31

45%

SM04554-AGA-04

P2

Completed

Alopecia Areata

2016-04-01

None

P1

Completed

Alopecia

2015-11-26

SM04554-AGA-02

P2

Completed

Alopecia Areata

2015-11-01

Recent News Events